Related Experiment Videos
Nephrotoxicity associated with combined gentamicin-amphotericin B therapy
Nephron
|January 1, 1977
Summary
Concurrent administration of amphotericin B and gentamicin may cause synergistic nephrotoxicity, leading to kidney function decline. This drug interaction requires careful monitoring in patients receiving both medications.
Area of Science:
- Nephrology
- Pharmacology
- Clinical Medicine
Background:
- Gentamicin, an aminoglycoside antibiotic, is known for its potential nephrotoxicity.
- Amphotericin B, an antifungal agent, also carries a risk of renal adverse effects.
Observation:
- Four patients receiving gentamicin concurrently with a low total dose of amphotericin B experienced significant renal function deterioration.
- In three of these cases, no alternative cause for the observed renal dysfunction was identified.
Findings:
- The combined use of amphotericin B and gentamicin appears to result in synergistic nephrotoxicity.
- This synergistic effect suggests an enhanced risk of kidney damage when these two drugs are co-administered.
Implications:
- Clinicians should exercise caution when prescribing amphotericin B to patients already on gentamicin therapy.
- Close monitoring of renal function is crucial in patients receiving this drug combination to mitigate potential kidney injury.